About BioMimetic Therapeutics
BioMimetic Therapeutics is a company based in Franklin (United States) founded in 2000 was acquired by Wright Medical in November 2012.. The company has 58 employees as of December 31, 2022. BioMimetic Therapeutics operates in a competitive market with competitors including Horizon Therapeutics, Humacyte, Osteal Therapeutics, ZetaGen and Angitia, among others.
- Headquarter Franklin, United States
- Employees 58 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$2.92 M (USD), Post-IPO
Jun 25, 2009
-
Investors
Wright Medical
& 5 more
-
Employee Count
58
as on Dec 31, 2022
-
Acquired by
Wright Medical
(Nov 19, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioMimetic Therapeutics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $2.9M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Post-IPO - BioMimetic Therapeutics | Valuation |
investors |
|
| Apr, 2009 | Amount | Post-IPO - BioMimetic Therapeutics | Valuation |
investors |
|
| May, 2003 | Amount | Series B - BioMimetic Therapeutics | Valuation | MB Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioMimetic Therapeutics
BioMimetic Therapeutics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Wright Medical, Burrill and Company and InterWest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investing in IT and healthcare ventures.
|
Founded Year | Domain | Location | |
|
Capital and strategic direction are provided to life science companies.
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioMimetic Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioMimetic Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomimetic Therapeutics Comparisons
Competitors of BioMimetic Therapeutics
BioMimetic Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Humacyte, Osteal Therapeutics, ZetaGen and Angitia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Human tissue-based products are developed for vascular disease applications.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for bone regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for muscle, bone, and joint diseases are developed.
|
|
| domain | founded_year | HQ Location |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomimetic Therapeutics
Frequently Asked Questions about BioMimetic Therapeutics
When was BioMimetic Therapeutics founded?
BioMimetic Therapeutics was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Where is BioMimetic Therapeutics located?
BioMimetic Therapeutics is headquartered in Franklin, United States.
How many employees does BioMimetic Therapeutics have?
As of Dec 31, 2022, the latest employee count at BioMimetic Therapeutics is 58.
What does BioMimetic Therapeutics do?
BioMimetic Therapeutics was founded in 2000 in Franklin, United States, within the biotechnology sector. Emphasis is placed on the creation and market introduction of regenerative protein drug-device combinations. These are applied to address orthopedic injuries affecting bone, cartilage, ligaments, and tendons. Operations involve research, development, and distribution focused on musculoskeletal repair solutions, with activities conducted through the biomimetics.com domain.
Who are the top competitors of BioMimetic Therapeutics?
BioMimetic Therapeutics's top competitors include Humacyte, Horizon Therapeutics and CUTISS.
Who are BioMimetic Therapeutics's investors?
BioMimetic Therapeutics has 6 investors. Key investors include Wright Medical, Burrill and Company, InterWest, MB Venture Partners, and HoldenCAPITAL.